With 80-85% of colposcopy exam results coming back negative, it is much easier for doctors to reassure their patients by using the DySIS colposcope
Tampa, FL (PRWEB) June 03, 2016
DySIS Medical, Inc. announced today that seven OB/GYN practices are among the latest offices implementing the DySIS Advanced Cervical Imaging system, which assists in the early detection of cervical cancer.
Asna Wellness Medical OB/GYN (Astoria, NY), Miami Center of Excellence for Obstetrics & Gynecology (Miami, FL), Plaza OB/GYN Associates (Houston, TX), Lifecircle Women’s Health (Palos Heights, IL), Sarasota OB/GYN Associates (Sarasota, FL), University Park Obstetrics & Gynecology, LLC (Sarasota, FL) and Women’s Personal Physicians (Miami, FL) recently adopted the DySIS digital colposcope, which can enhance a doctor’s ability to diagnose and manage cervical neoplasia by detecting changes in a woman’s cervix after an abnormal Pap smear.
More than 12,000 women are diagnosed with cervical cancer each year in the U.S. and many of those women will be among the millions of people recognized on Sunday, June 5th for the 29th annual National Cancer Survivors Day. However, even after treatment, women who have had cervical cancer have a greater chance of recurrence, which often creates additional anxiety for those cervical cancer survivors.
One goal of the National Cancer Survivors Day Foundation is to bring attention to the hardships cancer survivors still face, including emotional distress. Fortunately, the DySIS colposcope is technology that not only assists physicians in identifying pre-cancerous or cancerous cells on the cervix, but also provides reassurance to women through its high-resolution imagery and easy-to-read color-coded map of the cervix.
“With 80-85% of colposcopy exam results coming back negative, it is much easier for doctors to reassure their patients by using the DySIS colposcope. And a recent poster presented at the American Association of Colposcopy and Cervical Pathology conference demonstrated that cervical cancers can be small and easy to miss in the early stages,” says Kim Stebbings, U.S. President of DySIS Medical. “This technology provides additional information to the physician and enables the patient to be involved in the diagnostic process – putting her more at ease.”
Colposcopy, which can be subjective and has remained unchanged for decades, is an exam performed after a woman has an abnormal Pap smear. DySIS has advanced the standard colposcopy technique by using digital imaging technology that assists physicians in detecting changes in a woman’s cervix and helping guide biopsy selection to determine the best course of treatment to prevent cervical cancer.
“We are excited that hundreds of physicians across the U.S. have now recognized the importance of advancing today’s cervical screening technology and that by standardizing this subjective procedure, we can help improve care for women, including ongoing exams for cervical cancer survivors,” Stebbings said.
About DySIS Medical
DySIS Medical has its global headquarters in Edinburgh and US Headquarters in Tampa, FL. The company is committed to saving lives through the early detection and diagnosis of disease using biophotonic innovations. It aims to be the global leader in automated optical molecular imaging technologies for medical diagnostic and screening applications. For more information, please visit: http://www.dysismedical.com or call 844-DYSISMED.
About the DySIS colposcope
The DySIS colposcope differs from traditional colposcopes by measuring the cervical epithelium automatically using Dynamic Spectral Imaging and producing a map of the cervix, which assists the clinician with assessing the cervix, identifying biopsy locations and performing treatment if needed.
About cervical cancer
Worldwide, cervical cancer is the fourth most common cancer for women and the seventh most common cancer overall. While it is the only entirely preventable cancer, approximately half a million women are diagnosed with the disease every year.